// App-Quantinova.ai

1201M-362A : WHY DOES APICAL HYPERTROPHIC CARDIOMYOPATHY HAVE A FAVORABLE OUTCOME THAN NON-APICAL TYPES? CARDIAC MAGNETIC RESONANCE AND ECHOCARDIOGRAPHIC FINDINGS FROM 350 PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

Researchers

Presenter

  • Eun Kyoung Kim

Principal Investigators

  • Sang-Chol Lee

  • Hye Bin Gwag

  • Ji Won Hwang

  • Sung-A Chang

  • Sung-Ji Park

  • Seung Woo Park

  • Sung Mok Kim

  • Yeon Hyeon Choe

  • Jae K Oh

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

Disease

  • Hypertrophic cardiomyopathy

  • Diastolic dysfunction

  • Cardiac arrest

  • Myocardial fibrosis

  • Heart muscle disease

  • Congestive heart failure

  • Arrhythmia

  • Syncope

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved